000			02258 a2200637 4500
005			20250518024146.0
264		0	_c20191216
008			201912s 0 0 eng d
022			_a1532-1827
024	7		_a10.1038/s41416-019-0389-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aSerrano, César
245	0	0	_aComplementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours. _h[electronic resource]
260			_bBritish journal of cancer _c03 2019
300			_a612-620 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAnimals
650	0	4	_aCHO Cells
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aCricetulus
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aGastrointestinal Neoplasms _xdrug therapy
650	0	4	_aGastrointestinal Stromal Tumors _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate _xpharmacology
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aMutation
650	0	4	_aPhenylurea Compounds _xpharmacology
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-kit _xantagonists & inhibitors
650	0	4	_aPyridines _xpharmacology
650	0	4	_aSunitinib _xpharmacology
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aMariño-Enríquez, Adrián
700	1		_aTao, Derrick L
700	1		_aKetzer, Julia
700	1		_aEilers, Grant
700	1		_aZhu, Meijun
700	1		_aYu, Channing
700	1		_aMannan, Aristotle M
700	1		_aRubin, Brian P
700	1		_aDemetri, George D
700	1		_aRaut, Chandrajit P
700	1		_aPresnell, Ajia
700	1		_aMcKinley, Arin
700	1		_aHeinrich, Michael C
700	1		_aCzaplinski, Jeffrey T
700	1		_aSicinska, Ewa
700	1		_aBauer, Sebastian
700	1		_aGeorge, Suzanne
700	1		_aFletcher, Jonathan A
773	0		_tBritish journal of cancer _gvol. 120 _gno. 6 _gp. 612-620
856	4	0	_uhttps://doi.org/10.1038/s41416-019-0389-6 _zAvailable from publisher's website
999			_c29400435 _d29400435